You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 282 No. 22, December 8, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communication
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (84)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Mammography
 •Alert me on articles by topic

Continuing Screening Mammography in Women Aged 70 to 79 Years

Impact on Life Expectancy and Cost-effectiveness

Karla Kerlikowske, MD; Peter Salzmann, MD; Kathryn A. Phillips, PhD; Jane A. Cauley, DrPH; Steve R. Cummings, MD

JAMA. 1999;282:2156-2163.

Context  Mammography is recommended and is cost-effective for women aged 50 to 69 years, but the value of continuing screening mammography after age 69 years is not known. In particular, older women with low bone mineral density (BMD) have a lower risk of breast cancer and may benefit less from continued screening.

Objective  To compare life expectancy and cost-effectiveness of screening mammography in elderly women based on 3 screening strategies.

Design  Decision analysis and cost-effectiveness analysis using a Markov model.

Patients  General population of women aged 65 years or older.

Interventions  The analysis compared 3 strategies: (1) Undergoing biennial mammography from age 65 to 69 years; (2) undergoing biennial mammography from age 65 to 69 years, measurement of distal radial BMD at age 65 years, discontinuing screening at age 69 years in women in the lowest BMD quartile for age, and continuing biennial mammography to age 79 years in those in the top 3 quartiles of distal radius BMD; and (3) undergoing biennial mammography from age 65 to 79 years.

Main Outcome Measures  Deaths due to breast cancer averted, life expectancy, and incremental cost-effectiveness ratios.

Results  Compared with discontinuing mammography screening at age 69 years, measuring BMD at age 65 years in 10,000 women and continuing mammography to age 79 years only in women with BMD in the top 3 quartiles would prevent 9.4 deaths and add, on average, 2.1 days to life expectancy at an incremental cost of $66,773 per year of life saved. Continuing mammography to age 79 years in all 10,000 elderly women would prevent 1.4 additional breast cancer deaths and add only 7.2 hours to life expectancy at an incremental cost of $117,689 per year of life saved compared with only continuing mammography to age 79 years in women with BMD in the top 3 quartiles.

Conclusions  This analysis suggests that continuing mammography screening after age 69 years results in a small gain in life expectancy and is moderately cost-effective in those with high BMD and more costly in those with low BMD. Women's preferences for a small gain in life expectancy and the potential harms of screening mammography should play an important role when elderly women are deciding about screening.


Author Affiliations: Departments of Epidemiology and Biostatistics (Drs Kerlikowske, Phillips, and Cummings), Medicine (Drs Kerlikowske, Phillips, and Cummings), Clinical Pharmacy, School of Pharmacy (Dr Phillips); and General Internal Medicine Section, Department of Veterans Affairs (Dr Kerlikowske), University of California, San Francisco; Stanford University Graduate School of Business, Palo Alto, Calif (Dr Salzmann); and Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pa (Dr Cauley).


RELATED LETTER

Screening Mammography in Elderly Women
Jeanne Mandelblatt, K. Robin Yabroff, William Lawrence, Bin Yi, Grethen Orosz, Harrison G. Bloom, Clyde B. Schecther, Martine Extermann, Lodovico Balducci, William Satadano, Sarah Fox, Rebecca A. Silliman, Marianne C. Fahs, Peter Muening, for the Research on Breast Cancer in Older Women Consortium, Serge Rozenberg, Hamphrey Ham, Fabienne Liebens, David Seidenwurm, Jonathan Breslau, Karla Kerlikowske, Kathryn A. Phillips, Steve R. Cummings, Peter Salzmann, and Jane A. Cauley
JAMA. 2000;283(24):3202-3204.
EXTRACT | FULL TEXT  

RELATED ARTICLE

December 8, 1999
JAMA. 1999;282(22):2183-2184.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cost-Effectiveness of Digital Mammography Breast Cancer Screening
Tosteson et al.
ANN INTERN MED 2008;148:1-10.
ABSTRACT | FULL TEXT  

To Screen or Not to Screen Older Women for Breast Cancer: A New Twist on an Old Question or Will We Ever Invest in Getting the Answers?
Mandelblatt
JCO 2007;25:2991-2992.
FULL TEXT  

Influence of Computer-Aided Detection on Performance of Screening Mammography
Fenton et al.
NEJM 2007;356:1399-1409.
ABSTRACT | FULL TEXT  

Retrospective cost-effectiveness analysis of screening mammography.
Stout et al.
JNCI J Natl Cancer Inst 2006;98:774-782.
ABSTRACT | FULL TEXT  

Breast and Cervical Cancer Screening: Clinicians' Views on Health Plan Guidelines and Implementation Efforts
Zapka et al.
J Natl Cancer Inst Monogr 2005;2005:46-54.
ABSTRACT | FULL TEXT  

Benefits and Costs of Interventions to Improve Breast Cancer Outcomes in African American Women
Mandelblatt et al.
JCO 2004;22:2554-2566.
ABSTRACT | FULL TEXT  

Patient and Clinical Site Factors Associated With Rescreening Behavior Among Older Multiethnic, Low-Income Women
Fox et al.
Gerontologist 2004;44:76-84.
ABSTRACT | FULL TEXT  

The Cost-Effectiveness of Screening Mammography beyond Age 65 Years: A Systematic Review for the U.S. Preventive Services Task Force
Mandelblatt et al.
ANN INTERN MED 2003;139:835-842.
ABSTRACT | FULL TEXT  

Management of Influenza in Adults Older than 65 Years of Age: Cost-Effectiveness of Rapid Testing and Antiviral Therapy
Rothberg et al.
ANN INTERN MED 2003;139:321-329.
ABSTRACT | FULL TEXT  

Prevention of Herpes Simplex Virus Eye Disease: A Cost-effectiveness Analysis
Lairson et al.
Arch Ophthalmol 2003;121:108-112.
ABSTRACT | FULL TEXT  

References
Circulation 2002;106:3373-3421.
FULL TEXT  

A Randomized Clinical Trial to Assess the Benefit of Offering On-Site Mobile Mammography in Addition to Health Education for Older Women
Reuben et al.
Am. J. Roentgenol. 2002;179:1509-1514.
ABSTRACT | FULL TEXT  

Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force
Humphrey et al.
ANN INTERN MED 2002;137:347-360.
ABSTRACT | FULL TEXT  

Bone Mass and Breast Cancer Risk in Older Women: Differences by Stage at Diagnosis
Zmuda et al.
JNCI J Natl Cancer Inst 2001;93:930-936.
ABSTRACT | FULL TEXT  

Cancer Screening in Elderly Patients: A Framework for Individualized Decision Making
Walter and Covinsky
JAMA 2001;285:2750-2756.
ABSTRACT | FULL TEXT  

Screening Mammography in Elderly Women
Mandelblatt et al.
JAMA 2000;283:3202-3204.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.